Wholesale For Everyone has partnered with Cancer Link as the exclusive supplier of bandanas for the October "Country Pink" luncheon, an annual fundraiser supporting breast cancer research and early detection, under the auspices of Miami's Sylvester Comprehensive Cancer Center.Read Press Release
Breakthrough bioengineered, decellularized Wharton's Jelly matrix platform facilitates precision in vitro targeting of cancer stem cells (CSCs).
The Sanatela™ Matrix is a revolutionary, natural 3-D biomaterial that gives researchers a tool to cultivate and study stem cells, including cancer stem cells. This matrix tissue opens new research opportunities for the development of individualized cancer treatments in the lab and for High-Throughput Drug Screening applications by pharmaceutical and biotechnology companies.
Health and wellness will be the primary focus of the "Entre Nosotras" Health Fair, which will take place on July 13 from 10 a.m. to 12 p.m. at Ana G. Méndez University's South Florida Campus. A long list of experts will be participating in the health fair, providing different services and counseling to the community.Read Press Release
Jeff Ber at Oneball, Alberta Health Services, and the University of Calgary are working on a study to understand the impact of testicular cancer better.Read Press Release
Researchers will use IASLC/LCFA funds to create new lung cancer treatments for never-smokers and patients whose cancer has spreadRead Press Release
Planet TV Studios produces cutting-edge, real-life, television series that feature insightful, meaningful updates on the most important business, medical and social responsible topics currently taking place in the areas most important to our lives.Read Press Release
Flow cytometry provides a highly adaptable and quantitative method for investigating both the cellular distribution and intracellular changes that occur in tumors and peripheral lymphoid organs in response to therapy.Read Press Release
Presented by Covance Chief Scientific Officer Steve Anderson, Ph.D., and Covance Global Leader, Precision Medicine and Head, Biomarker Solution Center, Suso Platero, Ph.D., this webinar will address the spectrum of immunotherapy development considerations and their implications for drug developers.Read Press Release
In this study of 5,000 women, more women who received Paclitaxel once a week were likely to be alive and free of breast cancer five years after being diagnosed compared to women who received Paclitaxel every three weeks OR women who received Docetaxel (either weekly or every three weeks).Read Press Release